{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T18:13:19Z","timestamp":1780337599490,"version":"3.54.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1016\/j.biopha.2008.10.005","type":"journal-article","created":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T04:56:08Z","timestamp":1225515368000},"page":"577-585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Screening of potential prodrugs on cells derived from Dupuytren's disease patients"],"prefix":"10.1016","volume":"63","author":[{"given":"Sandra","family":"Kraljevic Pavelic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sinisa","family":"Bratulic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karlo","family":"Hock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davor","family":"Jurisic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijana","family":"Hranjec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Karminski-Zamola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biserka","family":"Zinic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maro","family":"Bujak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kresimir","family":"Pavelic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2008.10.005_bib1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.jhsb.2003.08.002","article-title":"A prospective randomised clinical trial of the intra-operative use of 5-fluorouracil on the outcome of Dupuytren's disease","volume":"29B","author":"Bulstrode","year":"2004","journal-title":"J\u00a0Hand Surg-Br Eur"},{"key":"10.1016\/j.biopha.2008.10.005_bib2","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1053\/jhsu.2002.35299","article-title":"Collagen as a clinical target: nonoperative treatment of Dupuytren's disease","volume":"27A","author":"Badalamente","year":"2002","journal-title":"J Hand Surg [Am]"},{"key":"10.1016\/j.biopha.2008.10.005_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/01.PRS.0000169701.16509.D6","article-title":"5-Fluorouracil selectively inhibits collagen synthesis","volume":"116","author":"Bulstrode","year":"2005","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.biopha.2008.10.005_bib4","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0266-7681(03)00135-9","article-title":"The different characteristics of Dupuytren's disease fibroblasts derived from either nodule or cord: expression of alpha-smooth muscle actin and the response, to stimulation by TGF-beta(1)","volume":"28B","author":"Bisson","year":"2003","journal-title":"J Hand Surg-Br Eur"},{"key":"10.1016\/j.biopha.2008.10.005_bib5","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1016\/S0002-9440(10)63764-9","article-title":"Myofibroblast differentiation is induced in keratinocyte-fibroblast co-cultures and is antagonistically regulated by endogenous transforming growth factor-beta and interleukin-1","volume":"164","author":"Shephard","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.biopha.2008.10.005_bib6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/J.JHSB.2005.07.002","article-title":"Dupuytren's contracture: an update of biomolecular aspects and therapeutic perspectives","volume":"30B","author":"Cordova","year":"2005","journal-title":"J Hand Surg-Br Eur"},{"key":"10.1016\/j.biopha.2008.10.005_bib7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1074\/jbc.M108103200","article-title":"Lefty contributes to the remodeling of extracellular matrix by inhibition of connective tissue growth factor and collagen mRNA expression and increased proteolytic activity in a fibrosarcoma model","volume":"277","author":"Mason","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.biopha.2008.10.005_bib8","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0749-0712(21)00443-1","article-title":"Nonoperative treatment of Dupuytren's disease","volume":"15","author":"Hurst","year":"1999","journal-title":"Hand Clin"},{"key":"10.1016\/j.biopha.2008.10.005_bib9","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0363-5023(96)80317-0","article-title":"Pharmacologic regulation of Dupuytren\u2019s fibroblast contraction in vitro","volume":"21A","author":"Rayan","year":"1996","journal-title":"J Hand Surg [Am]"},{"key":"10.1016\/j.biopha.2008.10.005_bib10","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1053\/jhsu.2000.6918","article-title":"Enzyme injection as nonsurgical treatment of Dupuytren's disease","volume":"25A","author":"Badalamente","year":"2000","journal-title":"J Hand Surg [Am]"},{"key":"10.1016\/j.biopha.2008.10.005_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1297-3203(00)73455-X","article-title":"The effect of 5-fluorouracil on Dupuytren fibroblast proliferation and differentiation","volume":"19","author":"Jemec","year":"2000","journal-title":"Chir Main"},{"key":"10.1016\/j.biopha.2008.10.005_bib12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1006\/jsre.2001.6350","article-title":"Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in Dupuytren's affected palmar fascia","volume":"103","author":"Kuhn","year":"2002","journal-title":"J Surg Res"},{"key":"10.1016\/j.biopha.2008.10.005_bib13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.mehy.2005.09.052","article-title":"Imiquimod: a potential weapon against Dupuytren contracture","volume":"66","author":"Namazi","year":"2006","journal-title":"Med Hypotheses"},{"key":"10.1016\/j.biopha.2008.10.005_bib14","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1054\/jhsb.2001.0742","article-title":"The effect of steroids on Dupuytren's disease: role of programmed cell death","volume":"27B","author":"Meek","year":"2002","journal-title":"J Hand Surg-Br Eur"},{"key":"10.1016\/j.biopha.2008.10.005_bib15","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/J.JHSB.2006.05.007","article-title":"Feedback inhibition of high TGF-beta 1 concentrations on myofibroblast induction and contraction by Dupuytren's fibroblasts","volume":"31B","author":"Wong","year":"2006","journal-title":"J Hand Surg-Br Eur"},{"key":"10.1016\/j.biopha.2008.10.005_bib16","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1081\/NCN-120023084","article-title":"Synthesis and antitumor activity of N-sulfonyl derivatives of nucleobases and sulfonamido nucleoside derivatives","volume":"22","author":"Zinic","year":"2003","journal-title":"Nucleosides Nucleotides Nucleic Acids"},{"key":"10.1016\/j.biopha.2008.10.005_bib17","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.bmc.2004.09.052","article-title":"The novel pyrimidine and purine derivatives of l-ascorbic acid: synthesis, one- and two-dimensional H-1 and C-13 NMR study, cytostatic and antiviral evaluation","volume":"13","author":"Gazivoda","year":"2005","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.biopha.2008.10.005_bib18","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1021\/jm040869i","article-title":"The novel l- and d-amino acid derivatives of hydroxyurea and hydantoins: synthesis, X-ray crystal structure study, and cytostatic and antiviral activity evaluations","volume":"48","author":"Opacic","year":"2005","journal-title":"J Med Chem"},{"key":"10.1016\/j.biopha.2008.10.005_bib19","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1016\/j.bmc.2005.12.004","volume":"14","author":"Jarak","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.biopha.2008.10.005_bib20","doi-asserted-by":"crossref","first-page":"5696","DOI":"10.1021\/jm070876h","article-title":"Novel cyano- and amidino-substituted derivatives of styryl-2-benzimidazoles and benzimidazo[1,2-a]quinolones. Synthesis, photochemical synthesis, DNA binding and antitumor evaluation","volume":"50","author":"Hranjec","year":"2007","journal-title":"J Med Chem"},{"key":"10.1016\/j.biopha.2008.10.005_bib21","first-page":"190","article-title":"Dupuytren disease: anatomy, pathology, presentation, and treatment","volume":"89A","author":"Rayan","year":"2007","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/j.biopha.2008.10.005_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0304-3835(01)00847-3","article-title":"Oncogenic functions of tumour suppressor p21 (Waf1\/Cip1\/Sdi1): association with cell senescence and tumour-promoting activities of stromal fibroblasts","volume":"179","author":"Roninson","year":"2002","journal-title":"Cancer Lett"},{"key":"10.1016\/j.biopha.2008.10.005_bib23","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S1368-7646(03)00044-X","article-title":"Differential effects of cell cycle regulatory protein p21(WAF1\/Cip1) on apoptosis and sensitivity to cancer chemotherapy","volume":"6","author":"Liu","year":"2003","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.biopha.2008.10.005_bib24","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0266-7681(91)90051-O","article-title":"An investigation into the role of inflammatory cells in Dupuytren's disease","volume":"16","author":"Andrew","year":"1991","journal-title":"J Hand Surg-Br Eur"},{"key":"10.1016\/j.biopha.2008.10.005_bib25","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/0140-6736(93)90760-E","article-title":"T-cell-mediated response in Dupuytren's disease","volume":"341","author":"Baird","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2008.10.005_bib26","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.4049\/jimmunol.156.9.3469","article-title":"Fas mediates apoptosis in human monocytes by a reactive oxygen intermediate dependent pathway","volume":"156","author":"Um","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.biopha.2008.10.005_bib27","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1054\/JHSB.1999.0207","article-title":"Dupuytren's disease. The way forward?","volume":"24","author":"Fitzgerald","year":"1999","journal-title":"J Hand Surg-Br Eur"},{"key":"10.1016\/j.biopha.2008.10.005_bib28","first-page":"1979","article-title":"Antineoplastic activity of novel N-1-sulfonypyrimidine derivatives","volume":"21","author":"Glavas-Obrovac","year":"2001","journal-title":"Anticancer Res"},{"key":"10.1016\/j.biopha.2008.10.005_bib29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nrm809","article-title":"Myofibroblasts and mechano-regulation of connective tissue remodelling","volume":"3","author":"Tomasek","year":"2002","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.biopha.2008.10.005_bib30","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1302\/0301-620X.85B3.13219","article-title":"Regulation of expression of alpha-smooth muscle actin in cells of Dupuytren's contracture","volume":"85","author":"Hindman","year":"2003","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.biopha.2008.10.005_bib31","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1073\/pnas.97.8.4291","article-title":"Effects of p21(Waf1\/Cip1\/Sdi1) on cellular gene expression: implications for carcinogenesis, senescence, and age-related diseases","volume":"97","author":"Chang","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.biopha.2008.10.005_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1302\/0301-620X.84B2.0840211","article-title":"Genetic susceptibility in Dupuytren's disease \u2013 TGF-beta 1 polymorphisms and Dupuytren's disease","volume":"84B","author":"Bayat","year":"2002","journal-title":"J Bone Joint Surg Br"},{"key":"10.1016\/j.biopha.2008.10.005_bib33","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1177\/095632020501600505","article-title":"Antiviral and cytostatic evaluation of the novel 6-acyclic chain substituted thymine derivatives","volume":"16","author":"Prekupec","year":"2005","journal-title":"Antivir Chem Chemother"},{"key":"10.1016\/j.biopha.2008.10.005_bib34","unstructured":"Zinic B, Krizmanic I, Zinic M. Synthesis of the sulfonylpyrimidine derivatives with anticancer activity. EP 0 887 022 B1 (Bulletin 1003\/16, 2003.)"},{"key":"10.1016\/j.biopha.2008.10.005_bib35","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1080\/07328319708006134","article-title":"Synthesis of the sulfonylpyrimidine derivatives as a new type of sulfonylcycloureas","volume":"16","author":"Kasnar","year":"1997","journal-title":"Nucleosides Nucleotides"},{"key":"10.1016\/j.biopha.2008.10.005_bib36","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0960-894X(01)00190-1","article-title":"Antitumor agents. Part 204: synthesis and biological evaluation of substituted 2-aryl quinazolinones","volume":"11","author":"Xia","year":"2001","journal-title":"Bioorg Med Chem Lett"}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332208003636?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332208003636?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T10:43:30Z","timestamp":1760093010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332208003636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0753332208003636"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2008.10.005","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening of potential prodrugs on cells derived from Dupuytren's disease patients","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2008.10.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}